Squarepoint Ops LLC Intra Cellular Therapies, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 317,754 shares of ITCI stock, worth $27.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

317,754

Previous 261,633 21.45%

Holding current value

$27.2 Million

Previous $17.9 Million 29.66%

% of portfolio

0.04%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.99 - $80.84 $3.82 Million - $4.54 Million	56,121 Added 21.45%	317,754 $23.2 Million
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $8.9 Million - $11 Million	137,432 Added 110.65%	261,633 $17.9 Million
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $5.35 Million - $6.28 Million	83,072 Added 201.98%	124,201 $8.59 Million
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $1.91 Million - $3.03 Million	41,129 New	41,129 $2.95 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $1.15 Million - $1.5 Million	26,260 New	26,260 $1.42 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $743,407 - $1.04 Million	17,410 New	17,410 $810,000
Q1 2022 May 16, 2022	SELL	$38.74 - $62.09 $225,273 - $361,053	-5,815 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.2 - $53.42 $204,688 - $310,637	5,815 New	5,815 $304,000
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $235,446 - $348,333	-8,198 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $240,201 - $364,811	8,198 New	8,198 $335,000
Q1 2021 May 17, 2021	SELL	$30.8 - $39.51 $330,422 - $423,863	-10,728 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $787,631 - $1.09 Million	-33,746 Reduced 75.88%	10,728 $341,000
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $783,187 - $1.42 Million	44,474 New	44,474 $1.14 Million
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $174,122 - $323,249	-12,134 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.31 - $33.12 $149,369 - $401,878	12,134 New	12,134 $186,000
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $1.07 Million - $5.67 Million	-147,257 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $700,028 - $1.31 Million	93,712 Added 175.02%	147,257 $1.1 Million
Q2 2019 Aug 14, 2019	BUY	$10.65 - $14.29 $148,844 - $199,717	13,976 Added 35.32%	53,545 $695,000
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $154,812 - $200,120	14,203 Added 55.99%	39,569 $482,000
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $8,277 - $16,747	799 Added 3.25%	25,366 $289,000
Q3 2018 Nov 14, 2018	SELL	$17.77 - $22.9 $282,525 - $364,087	-15,899 Reduced 39.29%	24,567 $533,000
Q2 2018 Aug 14, 2018	SELL	$17.33 - $23.4 $85,506 - $115,455	-4,934 Reduced 10.87%	40,466 $715,000
Q1 2018 May 15, 2018	BUY	$15.16 - $25.49 $688,264 - $1.16 Million	45,400 New	45,400 $956,000
Q4 2017 Feb 14, 2018	SELL	$14.27 - $16.79 $235,526 - $277,118	-16,505 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $177,758 - $364,760	16,505	16,505 $260,000

Others Institutions Holding ITCI

# of Institutions

377

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.09B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Intra Cellular Therapies, Inc. Transaction History